UMB Bank’s Medline Inc MDLN Stock Holding History

UMB Bank’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$789	Sell	20 -66	-77%	-$2.66K	﹤0.01%	2269
2026 Q1	$3.83K	Buy	+86	New	+$3.8K	﹤0.01%	2076

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UMB Bank's MDLN Position: Q2 2026 in Review

UMB Bank reduced its Medline Inc (MDLN) stake by 77% in Q2 2026, selling an estimated $2.66K and leaving 20 shares worth $789. The position accounts for ﹤0.01% of the portfolio, ranked #2269.

UMB Bank first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.83K in Q1 2026. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

UMB Bank held 20 shares of Medline Inc worth $789 as of Q2 2026.
UMB Bank sold 66 Medline Inc shares in Q2 2026, an estimated $2.66K.
Medline Inc made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #2269 holding.
UMB Bank first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
UMB Bank's Medline Inc position peaked at $3.83K in Q1 2026.
407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.